학술논문

Targeting S100A9 protein affects mTOR-ER stress signaling and increases venetoclax sensitivity in Acute Myeloid Leukemia.
Document Type
Article
Source
Blood Cancer Journal; 12/18/2023, Vol. 13 Issue 1, p1-12, 12p
Subject
ACUTE myeloid leukemia
VENETOCLAX
DRUG target
ENDOPLASMIC reticulum
CELL survival
AZACITIDINE
Language
ISSN
20445385
Abstract
Copyright of Blood Cancer Journal is the property of Springer Nature and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)